Prostatic and peripheral blood selenium levels after oral supplementation

Journal of Urology

Volumn 170, Issue 3, 2003, Pages 870-873

  Gianduzzo, T R J ^a   Holmes, E G ^a   Tinggi, U ^b   Shahin, M ^b   Mactaggart, P ^a   Nicol, D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

Chemoprevention; Prostate; Prostatic neoplasms; Selenium

Indexed keywords

SELENIUM;

ADULT; AGED; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CANCER INCIDENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRACE METAL BLOOD LEVEL; TRANSURETHRAL RESECTION;

EID: 0042737951     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000081052.51707.cf     Document Type: Article

References (20)

1. Barceloux, D. G.: Selenium. J Toxicol Clin Toxicol, 37: 145, 1999
2. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H. et al: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81: 730, 1998
3. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R. et al: SELECT: the next prostate cancer prevention trial. J Urol, 166: 1311, 2001
4. Costello, A. J.: A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. Urology, suppl., 57: 182, 2001
5. Reilly, C.: Selenium in food and health. London: Blackie Academic and Professional, 1996
6. Lü, J. and Combs, G. F., Jr.: Mechanism of selenium anticarcinogenesis. Unpublished data
7. Allan, C. B., Lacourciere, G. M. and Stadtman, T. C.: Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr, 19: 1, 1999
8. Feustel, A., Wennrich, R. and Dittrich, H.: Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology. Urol Res, 15: 161, 1987
9. Thomson, C. D. and Robinson, M. F.: Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am J Clin Nutr, 33: 303, 1980
10. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J. et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA, 276: 1957, 1996
11. Swanson, C. A., Patterson, B. H., Levander, O. A., Veillon, C., Taylor, P. R., Helzlsouer, K. et al: Human [74Se] selenomethionine metabolism: a kinetic model. Am J Clin Nutr, 54: 917, 1991
12. Tsalev, D. L.: Atomic Absorption Spectrometry in Occupational and Environmental Health Practice. Determination of Individual Elements. Boca Raton, Florida: CRC Press, Inc., vol. II, chapt. 26, pp. 167-178, 1984
13. Ferlay, J., Bray, F., Pisani, P. and Parkin, D. M.: GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. International Agency for Research on Cancer, Cancer Base No. 5. Available at http://www-dep.iarc.fr/globocan/globocan.html. Accessed April 3, 2002
14. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M. et al: Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst, 82: 864, 1990
15. Willett, W. C., Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S., Rosner, B. et al: Prediagnostic serum selenium and risk of cancer. Lancet, 2: 130, 1983
16. Coates, R. J., Weiss, N. S., Daling, J. R., Morris, J. S. and Labbe, R. F.: Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol, 128: 515, 1988
17. Hardell, L., Degerman, A., Tomic, R., Marklund, S. L. and Bergfors, M.: Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia. Eur J Cancer Prev, 4: 91, 1995
18. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B. et al: Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90: 1219, 1998
19. , Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., Nelson, W. G. et al: Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol, 166: 2034, 2001
20. Nomura, A. M., Lee, J., Stemmermann, G. N. and Combs, G. F., Jr.: Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 9: 883, 2000